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Definition
https ://en.wikipedia.org/wiki/Pulmonary_heart_disease
Cor pulmonale (pulmonary heart disease, right hear 
failure) is the enlargement and failure of the right 
ventricle of the heart as a response to increased 
vascular resistance (such as from pulmonic stenosis) 
or high blood pressure in the lungs.
Epidemiology
• Cor pulmonale is estimated to account for 6-7% of all types of adult 
heart disease in the United States, with chronic obstructive 
pulmonary disease (COPD) due to chronic bronchitis or emphysema 
the causative factor in more than 50% of cases
• In addition, cor pulmonale accounts for 10-30% of decompensated 
heart failure–related admissions in the United States 
• In contrast, acute cor pulmonale is usually secondary to massive 
pulmonary embolism that is the most common cause of acute life-
threatening cor pulmonale in adults (50,000 deaths in the United 
States)  
• Globally, the incidence of cor pulmonale varies widely among 
countries, depending on the prevalence of cigarette smoking, air 
pollution, and other risk factors for various lung diseases.
http://emedicine.medscape.com/article/154062-overview?pa=yxfMHIhqouVY2QjSZ271hAHLllINrXw0FEuNAGQi9d45R6qiJxgtX19AtDT%2B5dxG8SIvl8zjYv73GUyW5rsbWA%3D%3D#a3
Risk Factors and Etiology    
• Acute respiratory distress syndrome (ARDS)
• Chronic obstructive pulmonary disease (COPD)
• Primary pulmonary hypertension
• Blood clots in lungs
• Kyphoscoliosis
• Interstitial lung disease
• Cystic fibrosis
• Sarcoidosis
• Obstructive sleep apnea (untreated)
• Sickle cell anemia
• Bronchopulmonary dysplasia (in infants)
https://en.wikipedia.org/wiki/Pulmonary_heart_disease#Causes
Mechanism 1
• Pulmonary hypertension is the “sine qua non” of cor pulmonale 
• In chronic respiratory diseases pulmonary hypertension results from 
increased pulmonary vascular resistance (PVR) whereas cardiac 
output and pulmonary “capillary” wedge pressure are normal; 
pulmonary hypertension is said to be precapillary 
• The factors leading to an increased PVR in chronic respiratory disease 
are numerous but alveolar hypoxia is by far the most predominant, at 
least in COPD, kyphoscoliosis, and the obesity–hypoventilation 
syndrome
• Two distinct  mechanisms of action of alveolar hypoxia must be 
considered: acute hypoxia causes pulmonary vasoconstriction, and 
chronic longstanding hypoxia induces structural changes in the 
pulmonary vascular bed (pulmonary vascular remodelling) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1767533/
Mechanism 2
• Hypoxic pulmonary vasoconstriction (HPV) explains the rise of PVR 
and pulmonary arterial pressure (PAP) during acute hypoxia 
• Pulmonary hypertension is generally observed in respiratory patients 
exhibiting pronounced chronic hypoxaemia (PaO2 < 55–60 mm Hg)
• Chronic alveolar hypoxia leads to remodelling of the pulmonary 
vascular bed (hypertrophy of the muscular media of the small 
pulmonary arteries, muscularisation of pulmonary arterioles, and 
intimal fibrosis) comparable to that observed in natives living at high 
altitude 
• Other functional factors must be considered, namely hypercapnic 
acidosis and hyperviscosity caused by polycythemia, but their role 
seems small when compared to that of alveolar hypoxia 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1767533/
Mechanism 3
• In idiopathic pulmonary fibrosis the increase of PVR is caused by 
anatomical factors: loss of pulmonary vascular bed or compression of 
arterioles and capillaries by the fibrosing process 
• Pulmonary hypertension increases the work of the right ventricle, 
which leads more or less rapidly to right ventricular enlargement 
(associating hypertrophy and dilatation) which can result in 
ventricular dysfunction (systolic, diastolic)
• Cor pulmonale characterised by the presence of peripheral edema 
can be observed, at least in some respiratory patients
• The interval between the onset of pulmonary hypertension and the 
appearance of cor pulmonale is not known and may vary from one 
patient to another
• There is a relation between the severity of pulmonary hypertension 
and the development of cor pulmonale.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1767533/
Mechanism 4
• Acute cor pulmonale is result of pulmonary embolism (more 
common) and ARDS
• The underlying pathophysiology in a massive pulmonary embolism 
causing cor pulmonale is the sudden increase in pulmonary 
resistance
• In ARDS, RV overload can occur due to mechanical ventilation and the 
pathologic features of the syndrome itself
• Mechanical ventilation, especially higher tidal volumes, requires a 
higher transpulmonary pressure.
• In the case of ARDS, cor pulmonale is associated with an increased 
possibility of right-to-left shunting through a patent foramen ovale, 
which carries a poorer prognosis.
http://emedicine.medscape.com/article/154062-overview?pa=yxfMHIhqouVY2QjSZ271hAHLllINrXw0FEuNAGQi9d45R6qiJxgtX19AtDT%2B5dxG8SIvl8zjYv73GUyW5rsbWA%3D%3D#a2
Mechanism 5
https://www.netterimages.com/images/vpv/000/000/010/10281-0550x0475.jpg
Cor pulmonale and pulmonary embolism.
Mechanism 6
http://img.medscape.com/fullsize/migrated/458/659/src458659.fig4.gif
Mechanism of acute right heart failure: the vicious cycle.
Mechanism 7
https://www.netterimages.com/images/vpv/000/000/010/10281-0550x0475.jpg
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Mechanism 8
https://www.netterimages.com/images/vpv/000/000/010/10281-0550x0475.jpg
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Classification 
International Classification of Diseases  
http://apps.who.int/classifications/icd10/browse/2016/en#/J45
• X Diseases of the respiratory system
• Pulmonary heart disease and diseases of pulmonary 
circulation
(I26-I28)
• 126 Pulmonary embolism
• 127 Other pulmonary heart diseases
• 127.0 Primary pulmonary hypertension
• 127.1 Kyphoscoliotic heart disease
• 127.2 Other secondary pulmonary hypertension
• 127.8 Other specified pulmonary heart diseases
• 127.9 Pulmonary heart disease, unspecified 
Classification                                          
Clinical 1
http://cardiotextpublishing.com/cardiology-titles/braunwalds-heart-disease-review-and-assessment-10th-edition
1. Pulmonary arterial hypertension
1.1 Primary pulmonary hypertension
(a) Sporadic,  (b) Familial
1.2 Related to:
(a) Collagen vascular disease
(b) Congenital systemic to pulmonary shunts
(c) Portal hypertension
(d) HIV infection
(e) Drugs/toxins: (1) Anorexigens, (2) Other
(f ) Persistent pulmonary hypertension of the newborn
(g) Other 
Classification                                          
Clinical 2
http://cardiotextpublishing.com/cardiology-titles/braunwalds-heart-disease-review-and-assessment-10th-edition
2. Pulmonary venous hypertension: 2.1 Left sided atrial or ventricular 
heart disease, 2.2 Left sided valvar heart disease, 2.3 Extrinsic  
compression of central pulmonary veins: ((a) Fibrosing mediastinitis, 
(b) Adenopathy/tumours), 2.4 Pulmonary veno-occlusive disease, 
2.5 Other
3. Pulmonary hypertension associated with disorders of the respiratory 
system and/or hypoxaemia ( 3.1 Chronic obstructive pulmonary 
disease, 3.2 Interstitial lung disease, 3.3 Sleep disordered breathing, 
3.4 Alveolar hypoventilation disorders, 3.5 Chronic exposure to high  
altitude, 3.6 Neonatal lung disease, 3.7 Alveolar capillary dysplasia
3.8 Other 
Classification                                          
Clinical 3
http://cardiotextpublishing.com/cardiology-titles/braunwalds-heart-disease-review-and-assessment-10th-edition
4. Pulmonary hypertension caused by chronic thrombotic and/or 
embolic disease
4.1 Thromboembolic obstruction of proximal pulmonary arteries
4.2 Obstruction of distal pulmonary arteries ((a) Pulmonary embolism 
(thrombus, tumour, ova and/or parasites, foreign material), (b) In situ  
thrombosis, (c) Sickle cell disease)
5. Pulmonary hypertension caused by disorders directly affecting the 
pulmonary vasculature
5.1 Inflammatory ((a) Schistosomiasis, (b) Sarcoidosis, (c) Other)
5.2 Pulmonary capillary haemangomatosis.
Symptoms and Signs 1
• Shortness of breath
• Wheezing
• Cyanosis
• Ascites
• Jaundice
• Hepatomegaly
• Raised jugular venous pressure (JVP)
• Third heart sound
• Intercostal recession
• Presence of abnormal heart sounds
• Peripheral edema
https://en.wikipedia.org/wiki/Pulmonary_heart_disease#Signs_and_symptoms
Symptoms and Signs 2
https://s-media-cache-ak0.pinimg.com/originals/8c/b6/8b/8cb68b7c03b87a61906effb5eea9b4d8.jpg
Clinical Manifestations
• The clinical manifestations of cor pulmonale may be nonspecific
• The symptoms may be subtle, especially in early stages of the 
disease, and they may be mistakenly attributed to the underlying 
pulmonary pathology 
• Clinical signs are not sensitive indicators of pulmonary hypertension 
or right ventricular hypertrophy
• Peripheral edema is the best sign of right heart failure, but it is not 
specific and can arise from other causes.v
http://emedicine.medscape.com/article/154062-overview?pa=yxfMHIhqouVY2QjSZ271hAHLllINrXw0FEuNAGQi9d45R6qiJxgtX19AtDT%2B5dxG8SIvl 8zjYv73GUyW5rsbWA%3D%3D#a4
Complications
https://medlineplus.gov/ency/article/000129.htm
• Life-threatening shortness of breath
• Severe edema
• Shock
• Death.
Diagnosis
• A general approach to diagnose cor pulmonale starts with routine 
laboratory tests, chest radiography, and electrocardiography 
• Echocardiography gives information about the disease and right 
ventricular function 
• Right heart catheterization is the most accurate but invasive test to 
confirm the diagnosis 
• Pulmonary function tests may be required to confirm the presence of 
other lung pathologies
• Ventilation/perfusion scanning or chest computed tomography 
scanning may be performed if the patient’s history and physical 
examination suggest pulmonary thromboembolism 
• Imaging studies may show evidence of underlying cardiopulmonary 
diseases, pulmonary hypertension, or right ventricle  enlargement 
http://emedicine.medscape.com/article/154062-overview?pa=yxfMHIhqouVY2QjSZ271hAHLllINrXw0FEuNAGQi9d45R6qiJxgtX19AtDT%2B5dxG8SIvl 8zjYv73GUyW5rsbWA%3D%3D#a5
Diagnosis                                                    
Tests 1
• Laboratory investigations: 1) hematocrit for polycythemia, which can 
increase pulmonary arterial pressure by increasing viscosity, 2) serum 
alpha1-antitrypsin, if deficiency is suspected, 3) antinuclear 
antibodies level for collagen vascular disease, and scleroderma, 4) 
coagulations studies to evaluate hypercoagulability states 
• Arterial Blood Gas Analysis (level of oxygenation and type of acid-
base disorder)
• Brain natriuretic peptide (BNP): both congestive heart failure due to 
left ventricular failure and cor pulmonale can lead to elevations in 
plasma BNP
• Chest radiography: enlargement of the central pulmonary arteries 
and the right  ventricle (these findings have reduced sensitivity in the 
presence of kyphoscoliosis or hyperinflated lungs) 
http://emedicine.medscape.com/article/154062-overview#a6
Diagnosis                                                    
Tests 2
• Electrocardiographic abnormalities: right axis deviation, R/S 
amplitude ratio in V1 greater than 1; R/S amplitude ratio in V6 less 
than 1; an increase in P wave amplitude in leads 2, 3, and aVF; 
S 1 Q 3 T 3 pattern and right bundle branch block, low-voltage QRS , 
many rhythm disturbances 
• Two-dimensional echocardiography: signs of chronic right ventricular 
pressure overload 
• Doppler echocardiography:  increased pulmonary arterial pressure 
• Pulmonary Thromboembolism Imaging Studies: pulmonary 
angiography, computed tomography pulmonary angiography   
• Ultrafast, electrocardiographically-gated computed tomography: right 
ventricular function. 
http://emedicine.medscape.com/article/154062-overview#a10
Diagnosis                                                    
Tests 3
http://int-prop.lf2.cuni.cz/heart_sounds/ekg1/ekg-copd.gif
Diagnosis                                                    
Tests 4
http://www.radiologyassistant.nl/data/bin/a509797a67fe0d_groot-cor-pericard.jpg
Diagnosis                                                    
Tests 5
https://i.ytimg.com/vi/zaYxtKYthDk/maxresdefault.jpg
Diagnosis                                                    
Tests 6
https://i.ytimg.com/vi/zaYxtKYthDk/maxresdefault.jpg
Doppler shows a thick 
dense regurgitated jet. 
The estimated pulmonary 
artery systolic pressure is 
markedly elevated Adding 
on an right atrium. 
pressure of 15, which this 
individual had, yields a 
pulmonary artery systolic 
pressure of nearly 90 
mmHg.
Diagnosis                                                    
Tests 7
https://i.ytimg.com/vi/zaYxtKYthDk/maxresdefault.jpg
Computerized axial tomography  demonstrating bilateral main 
pulmonary artery emboli.
Diagnosis                                              
Differentiation
http://emedicine.medscape.com/article/154062-overview?pa=yxfMHIhqouVY2QjSZ271hAHLllINrXw0FEuNAGQi9d45R6qiJxgtX19AtDT%2B5dxG8SIvl8zjYv73GUyW5rsbWA%3D%3D#a5
• Atrial myxoma
• Blood disorders that are associated with increased blood viscosity
• Congestive (biventricular) heart failure
• Constrictive pericarditis
• High-output heart failure
• Infiltrative cardiomyopathies
• Primary pulmonic stenosis
• Right heart failure due to right ventricular infarction
• Right heart failure due to congenital heart diseases
• Ventricular septal defect.
Management
General
• Medical therapy for cor pulmonale is focused on treatment of the 
underlying pulmonary disease and improving oxygenation and right 
ventricular function 
• Oxygen therapy, diuretics, vasodilators, digitalis, theophylline, and 
anticoagulation therapy are all different modalities used in the long-
term management of chronic cor pulmonale 
• Cardiopulmonary support for acute cor pulmonale additionally 
includes fluid loading and vasoconstrictor (e.g., epinephrine) 
administration to maintain adequate blood pressure
• For massive pulmonary embolism in patients with acute cor 
pulmonale, consider administration of anticoagulation, thrombolytic 
agents or surgical embolectomy, especially if circulatory collapse is 
impending. 
http://emedicine.medscape.com/article/154062-overview#a18
Management
Oxygen Therapy
• Oxygen therapy is of great importance in patients with underlying 
chronic obstructive pulmonary disease (COPD),particularly when 
administered on a continuous basis ( the partial pressure of oxygen 
(PaO2) is likely to be below 55 mm Hg and decreases further with 
exercise and during sleep)
• Oxygen therapy relieves hypoxemic pulmonary vasoconstriction, 
lessens sympathetic vasoconstriction, alleviates tissue hypoxemia, and 
improves renal perfusion 
• Although the impact of oxygen therapy on survival in patients with cor 
pulmonale is unclear, it may provide some degree of symptomatic 
relief and improvement in functional status
• Oxygen therapy plays an important role in the immediate setting and 
long-term management, especially in patients who are hypoxic and 
have COPD.
http://emedicine.medscape.com/article/154062-overview#a19
Management
Pharmacotherapy 1
• Diuretics are used when the right ventricle filling volume is markedly 
elevated and in the management of associated peripheral edema 
• Vasodilators have been advocated in the long-term management of 
chronic cor pulmonale
• Calcium channel blockers (nifedipine, diltiazem), can lower pulmonary 
pressures, although these agents appear more effective in primary 
rather than secondary pulmonary hypertension 
• Beta-selective agonists have an additional advantage of 
bronchodilator and mucociliary clearance effect  
• Epoprostenol, treprostinil, and bosentan are prostacyclin analogues 
and have potent vasodilatory properties   
http://emedicine.medscape.com/article/154062-overview#a20
Management
Pharmacotherapy 2
• The endothelin receptor antagonists are indicated in idiopathic 
pulmonary artery hypertension as well as pulmonary hypertension 
secondary to connective tissue disorders 
• The PDE5 inhibitors (sildenafil, tadalafil ) function by preventing the 
degradation of cyclic GMP and subsequently prolonging the 
vasodilatory effect of nitric oxide; there are not enough data available 
yet regarding the efficacy of these drugs in patients with secondary 
pulmonary hypertension, such as in patients with COPD 
• Riociguat (a soluble guanylate cyclase stimulant that mimics the 
function of nitric oxide as well as acts synergistically with it to 
promote vasodilation) has been FDA approved for the treatment of 
group I pulmonary hypertension as well as group 4 pulmonary 
hypertension (chronic thromboembolic pulmonary hypertension) 
http://emedicine.medscape.com/article/154062-overview#a20
Management
Pharmacotherapy 3
• The use of cardiac glycosides, such as digitalis, must be used 
cautiously,  and should not be used during the acute phases of 
respiratory insufficiency when large fluctuations in levels of hypoxia 
and acidosis may occur 
• Theophylline has been reported to reduce pulmonary vascular 
resistance and pulmonary arterial pressures acutely in patients with 
chronic cor pulmonale secondary to COPD 
• Anticoagulation with warfarin is recommended in patients at high risk 
for thromboembolism 
• Thrombolytic therapy is indicated in patients with acute cor 
pulmonale due to a pulmonary embolism resulting in hemodynamic 
instability.   
http://emedicine.medscape.com/article/154062-overview#a20
Management
Surgical Approaches
• Phlebotomy is indicated in patients with chronic cor pulmonale and 
chronic hypoxia causing severe polycythemia, defined as hematocrit 
of 65% or more 
• Uvulopalatopharyngoplasty in selected patients with sleep apnea and 
hypoventilation may relieve cor pulmonale 
• Pulmonary embolectomy is indicated in patients with acute 
pulmonary embolism and hemodynamic instability when 
thrombolytic therapy is contraindicated, and in patients whose 
previous thrombolytic therapy failed, particularly if the location of 
the thrombus is in a more proximal location 
• Single-lung, double-lung, and heart-lung transplantation are all used 
to salvage the terminal phases of several diseases (e.g., emphysema, 
idiopathic pulmonary fibrosis, cystic fibrosis).
http://emedicine.medscape.com/article/154062-overview#a21
Management
Outpatient Monitoring
• Patients with cor pulmonale generally require close attention in the 
outpatient setting
• It is appropriate to regularly assess the patient’s oxygen needs and 
pulmonary function
• Consider a formal program of pulmonary rehabilitation, as many 
patients benefit from this therapy.
http://emedicine.medscape.com/article/154062-overview#a22
Prognosis
• The occurrence of documented cor pulmonale is an indicator of poor 
prognosis in respiratory patients 
• It is now accepted that a prolonged survival (≥ 10 years) can be 
observed after the first episode of peripheral edema
• The prevalence of clinical cor pulmonale has greatly decreased with 
the application of long term oxygen therapy, with a resulting 
improvement in prognosis. 
https ://www.ncbi.nlm.nih.gov/pmc/articles/PMC1767533/
Prophylaxis
Avoiding behaviors, such as cigarette smoking, which lead to chronic 
lung disease, may prevent the development of cor pulmonale.
http://www.nytimes.com/health/guides/disease/cor-pulmonale/overview.html
Abbreviations 
ARDS - acute respiratory distress syndrome
BNP - Brain natriuretic peptide 
CBC - complete blood count
CNS - central nervous system
COPD - chronic obstructive pulmonary disease
HPV - hypoxic pulmonary vasoconstriction 
ECMO - Extracorporeal membrane oxygenation 
ICU - intensive care unit 
JVP - jugular venous pressure
PAP - pulmonary arterial pressure 
PVR - pulmonary vascular resistance 
Diagnostic and treatment guidelines
2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary 
hypertension
Cor pulmonale
Cor pulmonale
The treatment of chronic cor pulmonale
Pulmonary hypertension (guidelines on diagnosis and treatment of)
Diagnosis and management of stable chronic obstructive pulmonary 
disease
